eröffnet am 30.01.19 09:12:51 von
neuester Beitrag 04.01.21 00:19:09 von

Beitrag schreiben

Begriffe und/oder Benutzer



 Ja Nein
30.01.19 09:12:51
...wird von Henry Schein abgespalten und das Vet-Geschäft betreiben:

Henry Schein Announces New Distribution Date And Anticipated When-Issued Trading Market For Spin-Off Of Animal Health Business

MELVILLE, N.Y., Jan. 16, 2019 /PRNewswire/ --

Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, announced today that in connection with the previously announced spin-off of its Henry Schein Animal Health Business, its Board of Directors has now changed from February 4, 2019 to February 7, 2019 the anticipated distribution date ("Distribution Date") for the distribution of shares of HS Spinco, Inc., the new company formed to effectuate the spin-off ("Spinco"), to shareholders of record of Henry Schein common stock as of January 17, 2019 (the "Record Date").

Spinco has filed an amended registration statement on Form S-4/S-1 (the "Amended Registration Statement") with the U.S. Securities and Exchange Commission ("SEC"), which has not yet become effective, relating to the planned spin-off and subsequent merger with Direct Vet Marketing, Inc. (d/b/a Vets First Choice), which is also anticipated to be consummated on the Distribution Date.

Investors may find an electronic copy of the Amended Registration Statement by searching for HS Spinco, Inc. at The Amended Registration Statement was filed to add additional language referenced in guidance recently published by the SEC regarding the ongoing U.S. federal government shutdown.

As previously announced, Spinco intends to list its common stock on the Nasdaq Global Select Market (the "Nasdaq") under the symbol "CVET" and will change its name to Covetrus, Inc. The spin-off will occur by way of a dividend of 0.4 of a share of Covetrus common stock for each share of Henry Schein common stock held on the Record Date. Henry Schein common stock will continue to trade on the Nasdaq under the symbol "HSIC."

It is also now anticipated that the Amended Registration Statement will become effective no later than February 4, 2019 (assuming a continuation of the U.S. federal government shutdown), rather than January 28, 2019. Once the Amended Registration Statement becomes effective, it is anticipated that trading of Covetrus common stock will begin on a "when-issued" basis (identified by the letter "v" at the end of the trading symbol - CVETV) and such trading will continue through the Distribution Date.

"Regular way" trading in Covetrus common stock will begin on the first trading day after the Distribution Date. It is also anticipated that once the Amended Registration Statement becomes effective and through the Distribution Date, there will be two markets in Henry Schein common stock: a "regular-way" market and an "ex-distribution" market (identified by the letter "v" at the end of the trading symbol - HSICV). Henry Schein common stock that trades on the regular-way market will trade with an entitlement to the Covetrus common stock to be distributed in the spin-off, and shares that trade on the ex-distribution market will trade without an entitlement to the Covetrus common stock to be distributed in the spin-off.

Following the distribution, Henry Schein intends to file with the Canada Revenue Agency (CRA) to attempt to qualify the distribution as an "eligible distribution" so that Canadian stockholders can make a special election under Section 86.1 of the Canada Income Tax Act in respect of the distribution of Spinco shares.
15.02.19 07:43:47
meine spin-off (Bruch)stücke wurden heute eingebucht
15.02.19 08:02:06
22.08.19 09:45:31
bisher nicht der Brüller, für die Q2-Ergebnisse gab's 'nen 33% haircut:
Covetrus | 12,45 €
1 Antwort
22.08.19 10:00:30
Antwort auf Beitrag Nr.: 61.315.408 von R-BgO am 22.08.19 09:45:31
Spree Capital ist aber überzeugt:

Covetrus | 12,45 €
20.02.20 20:20:29

--> wieso haben die denn ab 2019Q1 so viele Schulden??

--> jedenfalls verkaufte man schon einen Teil weiter an Heska (scil animal care business)

Auch türmen sich hier die Class Actions. CFO ging auch schon, und bei CEO und BoD gab es einen Rollentausch.
Covetrus | 12,63 $
1 Antwort
04.01.21 00:19:09
Antwort auf Beitrag Nr.: 62.742.322 von faultcode am 20.02.20 20:20:29störte alles nicht:

wie woanders auch, finanziert man sich durch die Ausgabe neuer Aktien:

Covetrus | 28,75 $

Beitrag zu dieser Diskussion schreiben